Skip to main content
The Oncologist logoLink to The Oncologist
. 2023 Mar 9;28(5):e315. doi: 10.1093/oncolo/oyad071

Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs

PMCID: PMC10166174  PMID: 36892975

This is a correction to: Aaron P. Mitchell, Akriti Mishra Meza, Niti U. Trivedi, Peter B. Bach, Mithat Gönen, Physician Payments from Pharmaceutical Companies Related to Cancer Drugs, The Oncologist, Volume 27, Issue 10, October 2022, Pages 857–863, https://doi.org/10.1093/oncolo/oyac160

In the originally published version of this article, some information was missing from the Funding section. The complete funding information is as follows: “Funding received from NIH, NCI P30CA008748 and NCI R37CA264563, and the National Institute for Health Care Management Foundation, GC260700. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.”

This error has now been corrected online.


Articles from The Oncologist are provided here courtesy of Oxford University Press

RESOURCES